News and Trends 4 Dec 2019 €48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases …are the only ones to target butyrophilins, which might allow new drug options in patients that don’t respond to one type of immunotherapy. ImCheck’s CMO, Paul Frohna, told me that… December 4, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Looking for cancer clues? Copper may open new drug treatment doors …test tube experiments. They discovered that the protein binds copper, but only the reduced form of copper. It is this form of copper ions that is most common in living… November 10, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2023 Researchers discover how tumor cells become resistant to colorectal cancer chemotherapy Platinum-based chemotherapy, which is used to treat advanced colorectal cancer, accumulates in the healthy cells surrounding the cancer cells and, as a result, can reduce tumor sensitivity to treatment. This… February 24, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 10 Nov 2023 How biotech can mend a broken heart …different countries. But there is already a project internally that we are pushing forward to get into the next stage, the next generation of a technology platform that would be… November 10, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2023 Lab-grown babies on the horizon: how IVG could transform human reproduction …taking skin cells down the pathway towards eggs, reprogramming them to embryonic-like stem cells, and then into primordial germ cells, which are early cells that emerge as an embryo develops,… August 22, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Discovery of how metastatic cancer cells infiltrate the liver may lead to new drugs …the development of drugs to prevent and treat metastatic liver cancer. Metastasizing cancer cells are known to change the microenvironment of liver cells in ways that promote metastasis, but the… October 4, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2020 T-Cell Discovery Could Herald Universal Cancer Immunotherapy An international research team has found a new type of T-cell that could lead to cell immunotherapies able to treat cancers beyond the reach of current CAR T-cell therapies. Market-approved… January 21, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2023 Immune memory research could lead to next generation of epigenetic drugs …cells) with cells previously exposed to antigen (memory cells). They focused on the differences in the epigenetic control of the cellular machinery and the nuclear architecture of the cells, two… July 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 27 Aug 2025 Zemcelpro, the first blood cord expansion therapy to reach the EU market …addresses this by using UM171, a small molecule designed to expand the number of stem cells while keeping them functionally intact. The expanded product contains two components: CD34+ cells that… August 27, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Startup Scout 18 Oct 2019 This Biotech Fights Autoimmune Disease with Rare Immune Cells …trials in three years. What we think: There is a strong need for autoimmune disease drugs that are able to restrain autoimmune cells while leaving the rest of the immune… October 18, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2022 New discovery could lead to drug development for brain cancer …astrocytes are essential to tumor progression and survival. Therefore, we investigated the underlying mechanisms: How do astrocytes transform from cells that support normal brain activity into cells that support malignant… September 1, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Sep 2019 UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost …lymphocytes from patients’ tumor samples. The company cultures the T cells and clones the ones that target neoantigens — proteins that are on the surface of the patients’ cancer cells…. September 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email